OK Biotech Co., Ltd.

TWSE:4155 Voorraadrapport

Marktkapitalisatie: NT$3.6b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

OK Biotech Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jia De Lai

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO0.2%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurless than a year

Recente managementupdates

Recent updates

OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

Aug 20
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Apr 26
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

Apr 04
Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Mar 01
Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

Feb 15
Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At OK Biotech's (TPE:4155) Share Price Returns

Jan 31
A Look At OK Biotech's (TPE:4155) Share Price Returns

We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Jan 17
We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Jan 03
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Dec 21
Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Nov 23
Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

CEO

Jia De Lai

no data

Tenure

Jia De Lai serves as the Chairman and Managing Director of OK Biotech Co., Ltd and serves as its Manager.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Jia De Lai
Managerno datageen gegevens0.23%
NT$ 8.2m
Qi Zheng Hou
CFO, Financial Managerless than a yeargeen gegevens0.021%
NT$ 745.4k
De Zhang
Chief Operating Officerno datageen gegevensgeen gegevens
De Wang
Business Office Associateno datageen gegevensgeen gegevens
Yuan Chen
Independent Directorno datageen gegevensgeen gegevens
Yun Xie
Independent Directorno datageen gegevensgeen gegevens
Chao Jiang
Independent Directorno datageen gegevensgeen gegevens
De Zhang
Directorno datageen gegevens2.04%
NT$ 72.9m
Ching Piao Chen
Directorless than a yeargeen gegevens0.99%
NT$ 35.4m
Chen Kang Wang
Directorless than a yeargeen gegevens0.099%
NT$ 3.5m
Chin Yuan Hsu
Directorless than a yeargeen gegevensgeen gegevens
Shin Wan Lan
Directorless than a yeargeen gegevens0.56%
NT$ 19.9m

0.3yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 4155 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.3 jaar), wat duidt op een nieuw bestuur.